half yearly, gsk fim and strategic alliances, page-21

Mad

I have to disagree, the announcements are getting easier and straight forward as we go. The stuff they can talk about they are sharing. What were you expecting? These updates are just a revisit as to where we have been and what box was ticked as at a period.

Not allowed to talk about original fmcg therefore no news. frustrating as shareholder
Strategic fmcg testing progressing last update they only received the compounds. This will take months.
Gallaxo doing in vivo in early 2011. next step along the path.

By the way expecting some resistance as the capper tries to hold onto control.